Literature DB >> 31088610

A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.

Miki Takahara1, Toshihiro Nagato2, Yui Nozaki2, Takumi Kumai3, Akihiro Katada2, Tatsuya Hayashi3, Yasuaki Harabuchi2.   

Abstract

IgA nephropathy (IgAN) is a tonsil-related disease. We previously showed that oligodeoxynucleotides with CpG (CpG-ODN) and B-cell activation factor (BAFF) are involved in hyperproduction of IgA from tonsillar mononuclear cells of patients with IgAN (IgAN-TMCs). In this study, we focused on a proliferation-inducing ligand (APRIL), homologous to BAFF. IgAN-TMCs produced more APRIL than non IgAN-TMCs in the presence of both CpG-ODN and control-ODN. TLR9 expression was higher in B-cells of IgAN-TMCs, and treatment with CpG-ODN enhanced transmembrane activator and CAML interactor (TACI) expression. IgA production from IgAN-TMCs was inhibited by APRIL neutralization antibody or TACI blocking antibody, and enhanced by co-treatment of APRIL and CpG-ODN. Serum APRIL levels were higher in patients with IgAN, and decreased after tonsillectomy. These findings suggest that APRIL is involved in the hyperproduction of IgA from IgAN-TMCs, and that CpG-ODN enhanced APRIL-induced IgA production by increasing TACI expression on B-cells of IgAN-TMCs.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  A proliferation-inducing ligand (APRIL); IgA nephropathy (IgAN); Oligodeoxynucleotides with CpG (CPG-ODN); Tonsil-related disease

Mesh:

Substances:

Year:  2019        PMID: 31088610     DOI: 10.1016/j.cellimm.2019.103925

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

1.  Long-Term Beneficial Effects of Tonsillectomy on Patients with Immunoglobulin A Nephropathy.

Authors:  Takahito Moriyama; Kazunori Karasawa; Yoei Miyabe; Kenichi Akiyama; Yuko Iwabuchi; Shota Ogura; Tomo Takabe; Naoko Sugiura; Momoko Seki; Norio Hanafusa; Keiko Uchida; Kosaku Nitta
Journal:  Kidney360       Date:  2020-09-02

Review 2.  Cytokines and Production of Aberrantly O-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy.

Authors:  Taylor Person; R Glenn King; Dana V Rizk; Jan Novak; Todd J Green; Colin Reily
Journal:  J Interferon Cytokine Res       Date:  2022-07-06       Impact factor: 3.657

3.  Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG2 Monoclonal Antibody, in Healthy Volunteers.

Authors:  Mohit Mathur; Jonathan Barratt; Yusuke Suzuki; Frank Engler; Marcela F Pasetti; Jill Yarbrough; Susan Sloan; David Oldach
Journal:  Kidney Int Rep       Date:  2022-02-08

Review 4.  Treatment strategy with multidrug therapy and tonsillectomy pulse therapy for childhood-onset severe IgA nephropathy.

Authors:  Yukihiko Kawasaki
Journal:  Clin Exp Nephrol       Date:  2022-02-04       Impact factor: 2.801

5.  microRNA-630 Regulates Underglycosylated IgA1 Production in the Tonsils by Targeting TLR4 in IgA Nephropathy.

Authors:  Chan Liu; Mu-Yao Ye; Wen-Zhe Yan; Xiao-Fei Peng; Li-Yu He; You-Ming Peng
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561

Review 6.  New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid.

Authors:  Da-Wei Lin; Cheng-Chih Chang; Yung-Chien Hsu; Chun-Liang Lin
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

Review 7.  The Role of Immune Modulation in Pathogenesis of IgA Nephropathy.

Authors:  Sheng Chang; Xiao-Kang Li
Journal:  Front Med (Lausanne)       Date:  2020-03-24

8.  Polyclonal B-cell lymphocytosis in English bulldogs.

Authors:  Emily D Rout; A Russell Moore; Robert C Burnett; Julia D Labadie; Kelly L Hughes; Paul A Navin; Janna A Yoshimoto; Paul R Avery; Anne C Avery
Journal:  J Vet Intern Med       Date:  2020-10-15       Impact factor: 3.333

Review 9.  Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.

Authors:  Jia-Wei He; Xu-Jie Zhou; Ji-Cheng Lv; Hong Zhang
Journal:  Theranostics       Date:  2020-09-15       Impact factor: 11.556

Review 10.  Role of Palatine Tonsil and Epipharyngeal Lymphoid Tissue in the Development of Glomerular Active Lesions (Glomerular vasculitis) in Immunoglobulin A Nephropathy.

Authors:  Osamu Hotta; Norio Ieiri; Masaaki Nagai; Ayaki Tanaka; Yasuaki Harabuchi
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.